| 1 |
35321335 | Omicron Variant of SARS-CoV-2 Virus: In Silico Evaluation of the Possible Impact on People Affected by Diabetes Mellitus. | 2022 |
2 |
| 2 |
35458513 | How Do Point Mutations Enhancing the Basic Character of the RBDs of SARS-CoV-2 Variants Affect Their Transmissibility and Infectivity Capacities? | 2022 Apr 10 |
1 |
| 3 |
33532796 | The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera. | 2021 Jan 29 |
1 |
| 4 |
33583954 | Computational search for drug repurposing to identify potential inhibitors against SARS-COV-2 using Molecular Docking, QTAIM and IQA methods in viral Spike protein - Human ACE2 interface. | 2021 May 15 |
1 |
| 5 |
33857328 | Can ketone bodies inactivate coronavirus spike protein? The potential of biocidal agents against SARS-CoV-2. | 2021 Jun |
2 |
| 6 |
34722943 | Characterization of peptide binding to the SARS-CoV-2 host factor neuropilin. | 2021 Oct |
1 |
| 7 |
32955901 | How do arbidol and its analogs inhibit the SARS-CoV-2? | 2020 |
1 |